Tagworks will present the click-cleavable ADC technology at the European Antibody Congress, taking place on the 29th-31st October in Basel. http://www.terrapinn.com/conference/european-antibody-congress/index.stm
Tagworks reports that the scope of its proprietary click-to-release reaction can be expanded from the cleavage of carbamates to ethers, potentially allowing more drug types to be released from their click-cleavable ADCs.
In mouse models of ovarian and aggressive colon cancer, Tagworks Pharmaceuticals has demonstrated the potent antitumour effect of the company’s ‘click-to-release’ bioorthogonal chemistry approach. The results are published in the journal Nature Communications
Raffaella Rossin, et al., Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice, Nature Communications (2018), doi:10.1038/s41467-018-03880-y
Tagworks’ CEO Marc Robillard is one of the speakers at Antibody Engineering & Therapeutics Europe 2018 in Amsterdam from 5-7 June.
Marc will present the company’s latest results on “Click chemistry-triggered drug release from a tumor-bound ADC” on Thursday 7 June. His lecture is part of a session on “Novel antibody-based therapeutics for cancer and immuno-oncology”
More information on the event: https://lifesciences.knect365.com/antibody-engineering-europe/speakers
Tagworks CEO Marc Robillard talks about entrepreneurship in the life sciences field and shares his experiences as co-founder of Tagworks Pharmaceuticals during the InnoBoot Session: Business meets Science at the StartupDelta Summit on Thursday April 19, 2018, in Arnhem, the Netherlands.
More information on the event: https://startupdeltasummit.com/overdesummit/
Tagworks CSO Raffaella Rossin presents the company’s latest research achievements on ‘In vivo click chemistry’ at the 19th European Symposium on Radiopharmacy and Radiopharmaceuticals (ESRR) in Groningen, the Netherlands on Friday, April 6, 2018.
More information: http://www.esrr.info/welcome-address/
Tagworks is featured in a BioCentury article on the state of the art and clinical prospects of in vivo click chemistry.
Tagworks CEO Marc Robillard will present at and co-chair the session on ‘Bioorthogonal and Click Chemistry for Molecular Imaging’ on Sunday October 21, 13:00-16:00, during the 30th Annual Conference of the European Association of Nuclear Medicine (EANM), October 21-25, 2017, Vienna, Austria.
More information on EANM’17: http://eanm17.eanm.org
Tagworks’ Research Manager Raffaella Rossin participates in the 22nd International Symposium on Radiopharmaceutical Sciences (iSRS) in Dresden, Germany, from May 14-19, 2017
More information on the conference: http://isrs2017.org
8-9 November 2017, 3rd Antibodies and Bio Therapeutics Congress, Las Vegas